Nearly 200 Medical School faculty members earned promotions in the 2024 cycle. Their new appointments were approved May 16 by the U-M Board of regents and take effect Sept. 1, 2024.

At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests

Former DCMB PhD student Dr. Shuze Wang was published in Developmental Cell.

Congratulations to incoming intern, Chioma Anidi on being the 2024 recipient of the Albert C. Furstenberg Award

Meet the newest residents to join our program

2 in 3 parents in national poll say their child ages 5-12 use personal audio devices; pediatrician offers 4 tips to reduce noise exposure risks

Elective surgery study shows older adults have concerns about what it will cost them, how much work they’ll miss and whether they’ll catch COVID-19.

As guest editor for a themed journal issue, Lori Pierce helps highlight the multiple factors that can make cancer care and prevention more equitable and reduce the burden of this disease for all

Vaccination against the coronavirus was much lower in adults and children with sickle cell disease despite a higher risk of severe COVID-19.

Research from Michigan Medicine experts is shedding light and potentially expanding options for patients living with an aggressive childhood cancer.

With over 400 stories published on Health Lab in 2023, the following 10 articles were the most read of the year.

Babies born with sickle cell disease face social inequality as well as a lifelong chronic disease that is often undertreated with proven drugs.

A car accident at age 20 left Sahar Mashhour in the intensive care unit for three months. Almost six years later, Mashhour is still pursuing her passions proving that her disability doesn’t limit her ability, but instead helps her see life through a different lens.

Infants with hemophilia A who received monoclonal antibody emicizumab experienced few bleeding events and no serious complications, a study suggests.

Pearce, professor of epidemiology at the School of Public Health and co-lead of Rogel’s cancer control and population sciences program, reflects on the project and why bringing this study to Michigan is so critical.